GC Therapeutics

North America Legal Chronicle. September 25, 2024

GC Therapeutics’ $65 Million Series A Financing Round

By Leila Ahmed

Wilson Sonsini Goodrich & Rosati advised GC Therapeutics on the transaction. GC Therapeutics (GCTx), a biopharmaceutical company, announced its launch and the completion of a $65...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

QXO’s $11 Billion Acquisition of Beacon Roofing Supply

Vice Media’s Acquisition of London Alley Entertainment

Hallstar’s Investment in Biorenuva

FMO’s US$23 Million Trade Facility to Volcafe

Carozzi’s Acquisition of 24.38% of the Shares of Empresas Carozzi

Cemig Geração e Transmissão’s R$625 Million Debentures Issuance

EFG Bank AG’s CHF340 Million Dual-Tranche Senior Unsecured Bonds Offering

Legrand Group’s €500 Million Bond Issuance

OCL Vision Group Ltd’s Minority Investment From BGF Investment Management

2PointZero’s Acquisition of Maseera Holding

Hyde Park Developments’ EGP2.6 Billion Medium-Term Financing

SolarAfrica Energy’s Financing of 114 MW SunCentral 1 PV Plant and Main Transmission Substation

Impact46’s $244 Million Sale of Shares in Rasan Information Technology

Benefit Systems’ Acquisition of Mars Spor Kulübü

Tabreed’s US$1.5 Billion Trust Certificate Issuance Programme and US$700 Million Green Certificates Issuance

Egis Group’s Dual Acquisitions of the Engeny and Peracon

Metal Powder Works’ Initial Public Offering

Navinci Global Markets’ Acquisition of Flight Simulation Business from Rex Airlines

Nelson Wilians Advogados advises on structuring innovative CRI with tokenization potential

Cleary Gottlieb Acquires Springbok AI

Supreme Court of El Salvador Blocks Enforcement of Arbitration Order in Continental Towers Dispute

Experienced Litigator Justin K. Beyer Joins Saul Ewing’s Chicago Office

O’Melveny Welcomes Acclaimed Technology Dealmaker Craig Menden

Delfino e Associati Willkie Farr & Gallagher LLP Strengthens its Public Law and International Trade & Compliance Team

GC Therapeutics’ $65 Million Series A Financing Round

Standard 1 Year Membership Required